Acute exacerbation of interstitial lung disease after procedures

Research output: Contribution to journalReview article

Abstract

Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

Original languageEnglish (US)
Pages (from-to)30-37
Number of pages8
JournalRespiratory Medicine
Volume150
DOIs
StatePublished - Apr 1 2019

Fingerprint

Interstitial Lung Diseases
Idiopathic Pulmonary Fibrosis
Decision Making
Fibrosis
Inflammation
Lung

Keywords

  • AE-ILD
  • Acute exacerbation
  • Acute exacerbation of interstitial lung disease
  • Interstitial lung disease
  • Lung biopsy

PubMed: MeSH publication types

  • Journal Article
  • Review

Cite this

@article{23fbdcd784e0423f92584202d34b0bd3,
title = "Acute exacerbation of interstitial lung disease after procedures",
abstract = "Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.",
keywords = "AE-ILD, Acute exacerbation, Acute exacerbation of interstitial lung disease, Interstitial lung disease, Lung biopsy",
author = "Amundson, {William H} and Racila, {Emilian V} and Allen, {Tadashi L} and Dincer, {H. Erhan} and Rade Tomic and Maneesh Bhargava and Perlman, {David M} and Kim, {Hyun J}",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.rmed.2019.02.012",
language = "English (US)",
volume = "150",
pages = "30--37",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Acute exacerbation of interstitial lung disease after procedures

AU - Amundson, William H

AU - Racila, Emilian V

AU - Allen, Tadashi L

AU - Dincer, H. Erhan

AU - Tomic, Rade

AU - Bhargava, Maneesh

AU - Perlman, David M

AU - Kim, Hyun J

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

AB - Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

KW - AE-ILD

KW - Acute exacerbation

KW - Acute exacerbation of interstitial lung disease

KW - Interstitial lung disease

KW - Lung biopsy

UR - http://www.scopus.com/inward/record.url?scp=85061673819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061673819&partnerID=8YFLogxK

U2 - 10.1016/j.rmed.2019.02.012

DO - 10.1016/j.rmed.2019.02.012

M3 - Review article

VL - 150

SP - 30

EP - 37

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

ER -